el-Azhary R A, Gibson L E, Kurtin P J, Pittelkow M R, Muller S A
Department of Dermatology, Mayo Clinic, Jacksonville, FL 32224.
J Am Acad Dermatol. 1994 Feb;30(2 Pt 1):210-8. doi: 10.1016/s0190-9622(94)70019-2.
Lymphomatoid papulosis (LyP) is a recurrent hemorrhagic papular skin eruption with a clinically benign course and histopathologic features of lymphoma.
To better characterize this disease, we studied 53 patients seen since 1965.
A lymphoproliferative malignancy developed within 2 to 36 years after onset of LyP in eight patients. Histologically, the dermis in LyP showed an infiltrate of large (type A) or small (type B) atypical lymphocytes. The large atypical cells (type A) stained with CD30 (Ber-H2). Seven of the patients in whom lymphoma developed had type A histologic features. DNA flow cytometry showed mainly a diploid pattern, except for two cases that showed aneuploidy. Five of 11 patients showed T-cell receptor (TCR) clonal gene rearrangements; lymphoma has not developed in these patients. One patient had a TCR rearrangement in a plaque of mycosis fungoides but not in the LyP lesion.
LyP is either a reactive skin condition or a localized lymphoid malignancy. Neither DNA flow cytometry nor TCR gene rearrangement can predict the 15% to 19% of patients in whom a lymphoma will develop. Continued observation of all patients is essential.
淋巴瘤样丘疹病(LyP)是一种复发性出血性丘疹性皮肤疹,临床病程呈良性,具有淋巴瘤的组织病理学特征。
为了更好地描述这种疾病,我们研究了自1965年以来诊治的53例患者。
8例患者在LyP发病后2至36年内发生了淋巴增殖性恶性肿瘤。组织学上,LyP的真皮层显示有大(A型)或小(B型)非典型淋巴细胞浸润。大的非典型细胞(A型)CD30(Ber-H2)染色阳性。发生淋巴瘤的7例患者具有A型组织学特征。DNA流式细胞术显示主要为二倍体模式,除2例显示非整倍体。11例患者中有5例显示T细胞受体(TCR)克隆性基因重排;这些患者尚未发生淋巴瘤。1例患者在蕈样肉芽肿斑块中有TCR重排,但在LyP病变中没有。
LyP要么是一种反应性皮肤疾病,要么是一种局限性淋巴恶性肿瘤。DNA流式细胞术和TCR基因重排均无法预测15%至19%会发生淋巴瘤的患者。对所有患者进行持续观察至关重要。